SeQuent Scientific Ltd
NSE:SEQUENT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
SeQuent Scientific Ltd
Cash & Cash Equivalents
SeQuent Scientific Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
SeQuent Scientific Ltd
NSE:SEQUENT
|
Cash & Cash Equivalents
₹626.6m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
5%
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Cash & Cash Equivalents
₹9.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Cash & Cash Equivalents
₹8B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
8%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Cash & Cash Equivalents
₹122.6B
|
CAGR 3-Years
32%
|
CAGR 5-Years
19%
|
CAGR 10-Years
-1%
|
|
|
Lupin Ltd
NSE:LUPIN
|
Cash & Cash Equivalents
₹30.4B
|
CAGR 3-Years
46%
|
CAGR 5-Years
18%
|
CAGR 10-Years
17%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Cash & Cash Equivalents
₹7.1B
|
CAGR 3-Years
27%
|
CAGR 5-Years
8%
|
CAGR 10-Years
1%
|
|
SeQuent Scientific Ltd
Glance View
SeQuent Scientific Ltd. manufactures and produces veterinary pharmaceuticals and specialty chemicals. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2016-03-10. The firm operates in the domains of animal health, in which it provides active pharmaceutical ingredient (APIs) and finished dosage formulations, and analytical services. The firm through its subsidiary, Alivira Animal Health Limited, offers APIs and formulations. Alivira Animal Health Limited has manufacturing facilities in five countries, including India. The Company’s subsidiary, Sequent Research Limited, is a contract research organization, which is engaged in analytical and biological analytical services to support the API, pharmaceutical, personal care and nutraceutical companies. Sequent Research Limited provides complete analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopeial monographs, customer-developed methods or in-house method development.
See Also
What is SeQuent Scientific Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
626.6m
INR
Based on the financial report for Jun 30, 2025, SeQuent Scientific Ltd's Cash & Cash Equivalents amounts to 626.6m INR.
What is SeQuent Scientific Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
5%
Over the last year, the Cash & Cash Equivalents growth was -3%. The average annual Cash & Cash Equivalents growth rates for SeQuent Scientific Ltd have been 2% over the past three years , -4% over the past five years , and 5% over the past ten years .
